ENTACAPONE

ENTACAPONE was reported 4253 times

ENTACAPONE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANAEMIA VITAMIN B6 DEFICIENCY 3 0.4286
1 DOPAMINE SUPERSENSITIVITY PSYCHOSIS 3 0.1875
2 DYSKINESIA HYPERPYREXIA SYNDROME 5 0.1064
3 DOPAMINE DYSREGULATION SYNDROME 41 0.0919
4 PARKINSONISM HYPERPYREXIA SYNDROME 16 0.0894
5 STOMA SITE HYPERSENSITIVITY 3 0.0882
6 MEDICAL DEVICE SITE ULCER 3 0.0625
7 CATHETER SITE INDURATION 10 0.0518
8 CAMPTOCORMIA 12 0.0500
9 PROGRESSIVE SUPRANUCLEAR PALSY 10 0.0498
10 ON AND OFF PHENOMENON 259 0.0466
11 MEDICAL DEVICE SITE DRYNESS 3 0.0462
12 PARKINSONIAN GAIT 28 0.0449
13 INFUSION SITE PAPULE 4 0.0421
14 FREEZING PHENOMENON 147 0.0397
15 JEALOUS DELUSION 11 0.0389
16 STOMA SITE IRRITATION 20 0.0368
17 CATHETER SITE NODULE 7 0.0366
18 SOMATIC DELUSION 9 0.0366
19 STOMA SITE REACTION 25 0.0365
20 REDUCED FACIAL EXPRESSION 36 0.0355
21 STEREOTYPY 32 0.0339
22 CATHETER SITE BRUISE 11 0.0332
23 STOMA SITE PAIN 43 0.0293
24 DEEP BRAIN STIMULATION 17 0.0281
25 STOMA SITE DISCHARGE 76 0.0277
26 STOMA SITE ERYTHEMA 51 0.0273
27 CATHETER SITE MASS 4 0.0263
28 HYPERSEXUALITY 48 0.0262
29 STOMA SITE INDURATION 3 0.0252
30 FIBROMA 23 0.0250
31 PATHOLOGICAL GAMBLING 38 0.0229
32 STOMA SITE DISCOMFORT 5 0.0220
33 HYPERKINESIA 46 0.0217
34 STOMA SITE INFLAMMATION 16 0.0214
35 ORGANIC BRAIN SYNDROME 4 0.0213
36 EAR, NOSE AND THROAT DISORDER 3 0.0213
37 STOMA SITE INFECTION 26 0.0200
38 SOFT TISSUE MASS 9 0.0195
39 EUTHANASIA 6 0.0189
40 STOMA SITE EXTRAVASATION 7 0.0181
41 CATHETER SITE IRRITATION 6 0.0180
42 STOMA SITE ODOUR 4 0.0179
43 DROPPED HEAD SYNDROME 7 0.0177
44 SWEAT DISCOLOURATION 3 0.0175
45 RESTING TREMOR 11 0.0170
46 COMPULSIVE SHOPPING 35 0.0170
47 IMPULSE-CONTROL DISORDER 35 0.0170
48 BRADYKINESIA 100 0.0169
49 DEPENDENT PERSONALITY DISORDER 3 0.0166
50 PERSEVERATION 3 0.0161
51 NEUROTRANSMITTER LEVEL ALTERED 3 0.0159
52 STOMA SITE HYPERGRANULATION 10 0.0158
53 MUTISM 23 0.0158
54 PARKINSON'S DISEASE 40 0.0157
55 THERAPEUTIC PRODUCT EFFECT VARIABLE 60 0.0154
56 GAMBLING 18 0.0154
57 SEXUALLY INAPPROPRIATE BEHAVIOUR 7 0.0150
58 SALIVA DISCOLOURATION 5 0.0150
59 ACUTE PSYCHOSIS 37 0.0149
60 SLEEP ATTACKS 7 0.0147
61 CATHETER SITE INJURY 3 0.0141
62 GLOSSOPTOSIS 3 0.0137
63 MUSCLE RIGIDITY 157 0.0131
64 STOMA SITE HAEMORRHAGE 20 0.0130
65 STOMA COMPLICATION 13 0.0128
66 NEUROGENIC BOWEL 3 0.0126
67 STOMA SITE ABSCESS 3 0.0123
68 PLEUROTHOTONUS 11 0.0122
69 DYSKINESIA 491 0.0121
70 PATIENT DISSATISFACTION WITH DEVICE 3 0.0119
71 OBSESSIVE-COMPULSIVE PERSONALITY DISORDER 3 0.0119
72 DELUSION OF GRANDEUR 5 0.0111
73 SPINAL CORD ABSCESS 3 0.0110
74 PATIENT ELOPEMENT 4 0.0109
75 REHABILITATION THERAPY 41 0.0106
76 AKINESIA 21 0.0101
77 LABELLED DRUG-FOOD INTERACTION MEDICATION ERROR 5 0.0100
78 RAPID EYE MOVEMENT SLEEP BEHAVIOUR DISORDER 4 0.0100
79 MASKED FACIES 4 0.0099
80 ILLUSION 16 0.0097
81 RECALL PHENOMENON 8 0.0096
82 INFUSION SITE NODULE 9 0.0094
83 CATHETER SITE RELATED REACTION 7 0.0093
84 HALLUCINATION, VISUAL 193 0.0091
85 LACK OF SPONTANEOUS SPEECH 4 0.0091
86 POST THROMBOTIC SYNDROME 4 0.0089
87 CHOREA 15 0.0087
88 YAWNING 23 0.0086
89 DEVICE CONNECTION ISSUE 18 0.0085
90 TORTICOLLIS 18 0.0085
91 PRODUCT DOSE CONFUSION 3 0.0085
92 DEVICE ALARM ISSUE 15 0.0083
93 OROMANDIBULAR DYSTONIA 6 0.0082
94 POSTURE ABNORMAL 26 0.0080
95 PRODUCT RESIDUE PRESENT 42 0.0078
96 SUICIDE THREAT 3 0.0077
97 WRONG DEVICE USED 5 0.0076
98 INFUSION SITE CELLULITIS 4 0.0076
99 GAMBLING DISORDER 20 0.0074
100 MARITAL PROBLEM 4 0.0074
101 EXECUTIVE DYSFUNCTION 4 0.0074
102 PERSECUTORY DELUSION 18 0.0072
103 DELUSION 112 0.0072
104 RAPID EYE MOVEMENTS SLEEP ABNORMAL 3 0.0071
105 AGONAL RESPIRATION 2 0.0071
106 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 7 0.0070
107 URGE INCONTINENCE 6 0.0069
108 HALLUCINATION, OLFACTORY 3 0.0069
109 HYPOMANIA 25 0.0068
110 HALLUCINATION 509 0.0067
111 DELUSIONAL DISORDER, UNSPECIFIED TYPE 5 0.0067
112 IMPULSIVE BEHAVIOUR 25 0.0067
113 BINGE EATING 7 0.0065
114 SUDDEN ONSET OF SLEEP 9 0.0065
115 SLEEP TALKING 11 0.0065
116 STREPTOCOCCAL BACTERAEMIA 7 0.0064
117 DYSTONIA 124 0.0064
118 DEVICE KINK 23 0.0063
119 INFUSION SITE HAEMATOMA 3 0.0063
120 TENSION 38 0.0062
121 BLOOD URIC ACID DECREASED 3 0.0062
122 FEAR OF FALLING 5 0.0061
123 LIVING IN RESIDENTIAL INSTITUTION 11 0.0059
124 BEZOAR 8 0.0058
125 SUSPICIOUSNESS 4 0.0057
126 ANTICHOLINERGIC SYNDROME 9 0.0056
127 MEDICAL DEVICE CHANGE 3 0.0056
128 ORTHOSTATIC INTOLERANCE 4 0.0056
129 DISORGANISED SPEECH 10 0.0054
130 LOGORRHOEA 19 0.0054
131 BEHAVIOUR DISORDER 29 0.0054
132 CATHETER SITE DISCHARGE 6 0.0053
133 MULTIPLE DRUG THERAPY 4 0.0053
134 HALLUCINATIONS, MIXED 22 0.0052
135 INFREQUENT BOWEL MOVEMENTS 13 0.0052
136 DISCOLOURED VOMIT 5 0.0052
137 ENTERAL NUTRITION 3 0.0052
138 BLADDER CATHETERISATION 5 0.0052
139 DERMATILLOMANIA 3 0.0050
140 ORTHOSTATIC HYPOTENSION 87 0.0050
141 DISINHIBITION 8 0.0050
142 AUTONOMIC NERVOUS SYSTEM IMBALANCE 14 0.0048
143 MONOCLONAL GAMMOPATHY 3 0.0048
144 NOCTURIA 58 0.0048
145 SOLILOQUY 4 0.0046
146 DEVICE LOOSENING 4 0.0046
147 DEVICE OCCLUSION 64 0.0045
148 FOOD INTERACTION 8 0.0045
149 HALLUCINATION, TACTILE 3 0.0045
150 COMPULSIONS 3 0.0045
151 DEMENTIA WITH LEWY BODIES 5 0.0045
152 FINE MOTOR SKILL DYSFUNCTION 13 0.0045
153 DEFAECATION DISORDER 3 0.0045
154 HEAT ILLNESS 3 0.0044
155 DRUG EFFECT VARIABLE 5 0.0044
156 NASAL OPERATION 3 0.0044
157 NEUROLEPTIC MALIGNANT SYNDROME 50 0.0042
158 VASCULAR PAIN 4 0.0042
159 DYSLALIA 3 0.0041
160 DIET REFUSAL 3 0.0041
161 INFUSION SITE WARMTH 5 0.0041
162 NONSPECIFIC REACTION 22 0.0040
163 OBSESSIVE-COMPULSIVE DISORDER 32 0.0040
164 TENDON DISCOMFORT 3 0.0040
165 LIBIDO INCREASED 8 0.0039
166 PSYCHOTIC BEHAVIOUR 4 0.0039
167 ANOSOGNOSIA 3 0.0039
168 CREATINE KINASE INCREASED 3 0.0039
169 IMMOBILE 17 0.0039
170 OBSESSIVE THOUGHTS 7 0.0039
171 COGWHEEL RIGIDITY 4 0.0038
172 INFUSION SITE BRUISING 8 0.0037
173 INFUSION SITE MASS 4 0.0037
174 DYSCHEZIA 11 0.0036
175 CATHETER SITE HAEMORRHAGE 9 0.0036
176 COLITIS MICROSCOPIC 17 0.0036
177 AMAUROSIS 3 0.0036
178 THERAPEUTIC RESPONSE SHORTENED 115 0.0035
179 FOLATE DEFICIENCY 4 0.0035
180 TERMINAL INSOMNIA 6 0.0034
181 ENERGY INCREASED 20 0.0034
182 INFUSION SITE INDURATION 5 0.0034
183 INFUSION SITE REACTION 10 0.0033
184 PSYCHOTIC DISORDER 97 0.0033
185 ABULIA 3 0.0032
186 FLUID INTAKE REDUCED 16 0.0032
187 GASTROINTESTINAL STOMA COMPLICATION 5 0.0032
188 PARANOIA 54 0.0031
189 THERAPEUTIC PRODUCT EFFECT DELAYED 14 0.0031
190 QUADRIPARESIS 5 0.0030
191 INFUSION SITE INFECTION 7 0.0030
192 DROWNING 3 0.0030
193 INFUSION SITE DISCOMFORT 3 0.0029
194 MICTURITION DISORDER 10 0.0029
195 INTERVERTEBRAL DISC COMPRESSION 3 0.0029
196 CONSCIOUSNESS FLUCTUATING 3 0.0029
197 INTENTIONAL UNDERDOSE 21 0.0029
198 THROMBOPHLEBITIS 10 0.0028
199 INTENSIVE CARE 4 0.0028
200 CATHETER SITE ERYTHEMA 6 0.0028
201 BOWEL MOVEMENT IRREGULARITY 21 0.0027
202 AORTIC VALVE SCLEROSIS 2 0.0027
203 NEGATIVE THOUGHTS 8 0.0027
204 WHEELCHAIR USER 12 0.0027
205 CATHETER SITE PAIN 7 0.0027
206 DEMENTIA 74 0.0026
207 ABNORMAL DREAMS 73 0.0026
208 INITIAL INSOMNIA 27 0.0026
209 DILATATION ATRIAL 3 0.0026
210 FACIAL PARESIS 9 0.0025
211 VOLVULUS 6 0.0025
212 CEREBRAL ATROPHY 10 0.0025
213 HYPOKINESIA 36 0.0025
214 JOINT DISLOCATION 26 0.0025
215 MOTOR DYSFUNCTION 25 0.0025
216 SHOULDER FRACTURE 4 0.0024
217 SLEEP DEFICIT 5 0.0024
218 PARKINSONISM 23 0.0024
219 HYPERTHERMIA 18 0.0024
220 DEVICE USE ISSUE 41 0.0023
221 BENIGN PROSTATIC HYPERPLASIA 12 0.0023
222 COGNITIVE DISORDER 108 0.0023
223 ADJUSTMENT DISORDER 3 0.0023
224 MANIA 38 0.0023
225 POOR QUALITY SLEEP 49 0.0023
226 TERMINAL STATE 15 0.0022
227 ABDOMINAL NEOPLASM 2 0.0022
228 HOSPICE CARE 22 0.0022
229 NASAL DISCHARGE DISCOLOURATION 3 0.0022
230 PSYCHOMOTOR HYPERACTIVITY 36 0.0022
231 DISCHARGE 3 0.0022
232 DELIRIUM 75 0.0022
233 SLOW SPEECH 5 0.0021
234 ATROPHY 4 0.0021
235 FAECES HARD 8 0.0021
236 DEVICE DISLOCATION 88 0.0020
237 DIPLEGIA 4 0.0020
238 SALIVARY HYPERSECRETION 20 0.0020
239 HYPOSMIA 3 0.0020
240 AGGRESSION 99 0.0020
241 DEVICE PHYSICAL PROPERTY ISSUE 15 0.0020
242 DEVICE PLACEMENT ISSUE 7 0.0020
243 PRODUCT PACKAGING DIFFICULT TO OPEN 5 0.0019
244 DEVICE MATERIAL ISSUE 4 0.0019
245 MEDICAL DEVICE PAIN 4 0.0019
246 ABNORMAL BEHAVIOUR 74 0.0019
247 BALANCE DISORDER 161 0.0019
248 RESTLESSNESS 68 0.0019
249 CATHETER SITE INFECTION 7 0.0018
250 FACE INJURY 7 0.0018
251 ABNORMAL FAECES 15 0.0018
252 WALKING AID USER 12 0.0018
253 AGITATION 133 0.0018
254 MOBILITY DECREASED 130 0.0018
255 SKIN MASS 12 0.0018
256 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 4 0.0018
257 FEMORAL NECK FRACTURE 9 0.0018
258 CHOKING 34 0.0017
259 DROOLING 12 0.0017
260 SPEECH DISORDER 91 0.0017
261 GAIT INABILITY 58 0.0017
262 CONFUSIONAL STATE 279 0.0017
263 CATATONIA 9 0.0017
264 DEVICE POWER SOURCE ISSUE 5 0.0017
265 HIP FRACTURE 55 0.0017
266 SPINAL STENOSIS 7 0.0017
267 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 81 0.0017
268 DIABETES INSIPIDUS 4 0.0017
269 INFUSION SITE ERYTHEMA 14 0.0017
270 HYPERPYREXIA 7 0.0017
271 TREMOR 273 0.0016
272 MEDICAL DEVICE DISCOMFORT 5 0.0016
273 PSYCHIATRIC SYMPTOM 12 0.0016
274 PNEUMOPERITONEUM 3 0.0016
275 MIDDLE INSOMNIA 30 0.0016
276 DEVICE ISSUE 144 0.0016
277 DYSPHEMIA 7 0.0016
278 INFECTED SKIN ULCER 3 0.0016
279 SPUTUM DISCOLOURED 15 0.0016
280 FORMICATION 11 0.0016
281 MECHANICAL VENTILATION 3 0.0016
282 ABDOMINAL INFECTION 4 0.0016
283 QUALITY OF LIFE DECREASED 21 0.0016
284 SEROTONIN SYNDROME 30 0.0016
285 PANIC DISORDER 6 0.0015
286 PELVIC FRACTURE 12 0.0015
287 ABDOMINAL WALL HAEMATOMA 3 0.0015
288 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 109 0.0015
289 NIGHTMARE 53 0.0015
290 URINARY RETENTION 51 0.0015
291 INJECTION SITE INFECTION 5 0.0015
292 INFUSION SITE HAEMORRHAGE 5 0.0015
293 DYSGRAPHIA 10 0.0015
294 CORONAVIRUS INFECTION 10 0.0015
295 HYPOPHAGIA 38 0.0015
296 EAR HAEMORRHAGE 3 0.0015
297 FALL 493 0.0015
298 MUSCLE CONTRACTURE 3 0.0015
299 DECUBITUS ULCER 12 0.0015
300 TROPONIN INCREASED 11 0.0014
301 TACHYPHRENIA 5 0.0014
302 RESTLESS LEGS SYNDROME 26 0.0014
303 GAIT DISTURBANCE 273 0.0014
304 NEUROGENIC BLADDER 3 0.0014
305 INCONTINENCE 15 0.0014
306 DEPRESSIVE SYMPTOM 5 0.0014
307 MUSCULOSKELETAL STIFFNESS 124 0.0014
308 PNEUMONIA ASPIRATION 35 0.0014
309 NASAL DISCOMFORT 11 0.0014
310 PANIC REACTION 10 0.0014
311 SOMNAMBULISM 9 0.0014
312 LUMBAR SPINAL STENOSIS 4 0.0014
313 ILEUS 17 0.0014
314 ANKLE OPERATION 2 0.0014
315 GASTROINTESTINAL ULCER 3 0.0014
316 APRAXIA 2 0.0013
317 FAILURE TO THRIVE 7 0.0013
318 MOVEMENT DISORDER 43 0.0013
319 ANAL INCONTINENCE 12 0.0013
320 GASTROINTESTINAL HYPOMOTILITY 3 0.0013
321 DRUG EFFECT DELAYED 6 0.0013
322 BRAIN OPERATION 3 0.0013
323 MASTICATION DISORDER 4 0.0013
324 UPPER LIMB FRACTURE 26 0.0013
325 HEAD INJURY 41 0.0013
326 DEPRESSED LEVEL OF CONSCIOUSNESS 51 0.0013
327 GASTRITIS EROSIVE 6 0.0013
328 HYPERSOMNIA 36 0.0013
329 WEIGHT ABNORMAL 3 0.0012
330 REFUSAL OF TREATMENT BY PATIENT 8 0.0012
331 EATING DISORDER 26 0.0012
332 LISTLESS 4 0.0012
333 INJECTION SITE ABSCESS 3 0.0012
334 PRESCRIBED UNDERDOSE 24 0.0012
335 HYPERPARATHYROIDISM SECONDARY 3 0.0012
336 TENSION HEADACHE 5 0.0012
337 HYPOPNOEA 4 0.0012
338 INGUINAL HERNIA 7 0.0011
339 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 3 0.0011
340 MICTURITION URGENCY 13 0.0011
341 MUSCLE CONTRACTIONS INVOLUNTARY 4 0.0011
342 DEPRESSED MOOD 60 0.0011
343 HALLUCINATION, AUDITORY 18 0.0011
344 SLEEP DISORDER 78 0.0011
345 URINE ABNORMALITY 5 0.0011
346 SCREAMING 7 0.0011
347 FAECALOMA 6 0.0011
348 INCOHERENT 7 0.0011
349 PANCREATITIS ACUTE 24 0.0011
350 BEDRIDDEN 14 0.0011
351 DYSSTASIA 31 0.0011
352 APHASIA 32 0.0011
353 SENSORY DISTURBANCE 17 0.0011
354 VITAMIN B12 DECREASED 3 0.0010
355 SOMNOLENCE 208 0.0010
356 UNEVALUABLE EVENT 78 0.0010
357 HYPOVOLAEMIA 6 0.0010
358 AFFECTIVE DISORDER 8 0.0010
359 DECREASED INTEREST 6 0.0010
360 DYSPHAGIA 96 0.0010
361 POLYNEUROPATHY 12 0.0010
362 DISTURBANCE IN ATTENTION 54 0.0010
363 DISORIENTATION 39 0.0010
364 PERIPHERAL VENOUS DISEASE 4 0.0010
365 EUPHORIC MOOD 10 0.0010
366 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 10 0.0010
367 SELF-MEDICATION 4 0.0010
368 SUICIDAL BEHAVIOUR 4 0.0010
369 RESPIRATORY RATE DECREASED 3 0.0010
370 MOOD ALTERED 26 0.0010
371 INFUSION SITE PRURITUS 3 0.0009
372 FOOD CRAVING 5 0.0009
373 MEMORY IMPAIRMENT 130 0.0009
374 BLADDER PAIN 3 0.0009
375 AORTIC VALVE INCOMPETENCE 4 0.0009
376 MYDRIASIS 12 0.0009
377 VENTRICULAR HYPOKINESIA 3 0.0009
378 GENERAL SYMPTOM 7 0.0009
379 DIZZINESS POSTURAL 9 0.0009
380 RIB FRACTURE 19 0.0009
381 CONSTIPATION 201 0.0009
382 SKIN LACERATION 10 0.0009
383 HAEMODYNAMIC INSTABILITY 7 0.0009
384 BRADYPHRENIA 6 0.0009
385 EMBEDDED DEVICE 9 0.0009
386 FOOT DEFORMITY 10 0.0009
387 PROSTATE CANCER METASTATIC 3 0.0009
388 ENCEPHALOPATHY 22 0.0009
389 IRRITABILITY 53 0.0009
390 CYSTITIS 28 0.0009
391 INJECTION SITE PAPULE 4 0.0009
392 CERVICAL VERTEBRAL FRACTURE 3 0.0009
393 URINARY TRACT INFECTION 147 0.0009
394 HYPERREFLEXIA 3 0.0009
395 PERSONALITY CHANGE 8 0.0009
396 FEAR 23 0.0009
397 DEVICE DIFFICULT TO USE 56 0.0008
398 GENERALISED TONIC-CLONIC SEIZURE 14 0.0008
399 LIMB DISCOMFORT 26 0.0008
400 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 8 0.0008
401 BLOOD CREATINE PHOSPHOKINASE INCREASED 24 0.0008
402 SHOCK 19 0.0008
403 DYSARTHRIA 31 0.0008
404 APATHY 12 0.0008
405 PARADOXICAL DRUG REACTION 3 0.0008
406 DEVICE BREAKAGE 33 0.0008
407 MUSCLE STRAIN 7 0.0008
408 GASTROINTESTINAL SOUNDS ABNORMAL 4 0.0008
409 MALNUTRITION 9 0.0008
410 GENERAL PHYSICAL HEALTH DETERIORATION 93 0.0008
411 INJECTION SITE INFLAMMATION 4 0.0008
412 MITRAL VALVE INCOMPETENCE 9 0.0008
413 PRODUCT COMMUNICATION ISSUE 7 0.0008
414 ORAL DISCOMFORT 11 0.0008
415 DYSPHORIA 4 0.0008
416 COMMUNICATION DISORDER 3 0.0008
417 GASTRIC INFECTION 3 0.0008
418 PETIT MAL EPILEPSY 4 0.0008
419 THERAPEUTIC PRODUCT EFFECT DECREASED 35 0.0008
420 MENTAL DISORDER 34 0.0008
421 OESOPHAGEAL ULCER 3 0.0008
422 EMOTIONAL DISORDER 24 0.0008
423 CEREBRAL ISCHAEMIA 4 0.0008
424 CARDIOPULMONARY FAILURE 3 0.0008
425 TENDON DISORDER 5 0.0008
426 RESPIRATORY ACIDOSIS 3 0.0008
427 UROSEPSIS 7 0.0008
428 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 13 0.0008
429 MENTAL STATUS CHANGES 21 0.0008
430 SUDDEN DEATH 8 0.0008
431 CHROMATURIA 17 0.0008
432 PRODUCT ADMINISTRATION ERROR 15 0.0007
433 TRANSIENT ISCHAEMIC ATTACK 25 0.0007
434 HIP SURGERY 4 0.0007
435 ABDOMINAL RIGIDITY 2 0.0007
436 UNRESPONSIVE TO STIMULI 19 0.0007
437 MUSCULOSKELETAL DISORDER 14 0.0007
438 DYSPHONIA 43 0.0007
439 POLYURIA 6 0.0007
440 HYPONATRAEMIA 41 0.0007
441 INTESTINAL ISCHAEMIA 4 0.0007
442 RESPIRATION ABNORMAL 5 0.0007
443 URINARY INCONTINENCE 21 0.0007
444 MUSCLE FATIGUE 3 0.0007
445 PRODUCT DISPENSING ISSUE 3 0.0007
446 BRAIN INJURY 7 0.0007
447 SOCIAL AVOIDANT BEHAVIOUR 4 0.0007
448 PRODUCT PRESCRIBING ISSUE 15 0.0007
449 DRUG EFFECT DECREASED 37 0.0007
450 SLUGGISHNESS 7 0.0007
451 MAJOR DEPRESSION 5 0.0007
452 SKIN HAEMORRHAGE 10 0.0007
453 VENTRICULAR EXTRASYSTOLES 7 0.0007
454 CATARACT OPERATION 4 0.0007
455 PRESCRIBED OVERDOSE 13 0.0007
456 CARDIAC PACEMAKER INSERTION 4 0.0007
457 WEIGHT FLUCTUATION 7 0.0007
458 DEVICE LEAKAGE 29 0.0007
459 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 31 0.0007
460 PAROSMIA 5 0.0007
461 MENTAL IMPAIRMENT 16 0.0007
462 SCOLIOSIS 4 0.0006
463 EXTRAPYRAMIDAL DISORDER 16 0.0006
464 INFUSION SITE SWELLING 4 0.0006
465 SKIN ABRASION 3 0.0006
466 PARALYSIS 9 0.0006
467 SUBDURAL HAEMATOMA 9 0.0006
468 BLOOD PRESSURE FLUCTUATION 15 0.0006
469 ROTATOR CUFF SYNDROME 8 0.0006
470 TREATMENT NONCOMPLIANCE 34 0.0006
471 INFUSION SITE PAIN 8 0.0006
472 GUILLAIN-BARRE SYNDROME 3 0.0006
473 ANTINUCLEAR ANTIBODY POSITIVE 2 0.0006
474 DRUG EFFECT LESS THAN EXPECTED 9 0.0006
475 FOOT OPERATION 3 0.0006
476 UNINTENTIONAL MEDICAL DEVICE REMOVAL 7 0.0006
477 INSOMNIA 161 0.0006
478 ABDOMINAL TENDERNESS 3 0.0006
479 APPETITE DISORDER 4 0.0006
480 HYPERNATRAEMIA 3 0.0006
481 DRY THROAT 6 0.0006
482 MYOCLONUS 7 0.0006
483 ABNORMAL LOSS OF WEIGHT 4 0.0006
484 FACIAL PARALYSIS 5 0.0006
485 CACHEXIA 3 0.0006
486 TRISMUS 3 0.0006
487 DRUG INTERACTION 92 0.0006
488 CONDITION AGGRAVATED 175 0.0006
489 UNDERDOSE 42 0.0006
490 MALABSORPTION 3 0.0006
491 PARTIAL SEIZURES 3 0.0006
492 MUSCULAR WEAKNESS 65 0.0006
493 ACUTE RESPIRATORY FAILURE 11 0.0006
494 SENSITIVITY TO WEATHER CHANGE 3 0.0006
495 SERUM FERRITIN INCREASED 3 0.0006
496 HAND FRACTURE 4 0.0006
497 ABSCESS 9 0.0006
498 CONTRAINDICATED PRODUCT ADMINISTERED 17 0.0006
499 BODY HEIGHT DECREASED 6 0.0006
500 APPENDICECTOMY 2 0.0006
501 GASTROINTESTINAL MOTILITY DISORDER 3 0.0006
502 INJECTION SITE DISCHARGE 3 0.0006
503 ADVERSE DRUG REACTION 50 0.0006
504 IMPAIRED QUALITY OF LIFE 8 0.0006
505 MUSCLE TIGHTNESS 9 0.0006
506 VISUAL FIELD DEFECT 4 0.0006
507 BLOOD PRESSURE ABNORMAL 11 0.0006
508 TONGUE DISORDER 4 0.0006
509 FAECES SOFT 4 0.0005
510 PANIC ATTACK 20 0.0005
511 ANXIETY 156 0.0005
512 ASPIRATION 6 0.0005
513 PRODUCT PRESCRIBING ERROR 13 0.0005
514 GASTROINTESTINAL PAIN 6 0.0005
515 PRODUCT PHYSICAL ISSUE 11 0.0005
516 INJECTION SITE NODULE 6 0.0005
517 CHOKING SENSATION 3 0.0005
518 FEEDING DISORDER 11 0.0005
519 DRY MOUTH 44 0.0005
520 SENSITIVE SKIN 4 0.0005
521 GASTRIC ULCER HAEMORRHAGE 3 0.0005
522 DIPLOPIA 14 0.0005
523 FEELING DRUNK 4 0.0005
524 THINKING ABNORMAL 10 0.0005
525 HYPERHIDROSIS 69 0.0005
526 INCORRECT DOSE ADMINISTERED BY DEVICE 14 0.0005
527 PERIORBITAL SWELLING 3 0.0005
528 SARS-COV-2 TEST POSITIVE 7 0.0005
529 FOOT FRACTURE 10 0.0005
530 GASTRIC ULCER 10 0.0005
531 VENTRICULAR SEPTAL DEFECT 3 0.0005
532 PRODUCT DOSE OMISSION 34 0.0005
533 MUSCLE TWITCHING 12 0.0005
534 HYPERVENTILATION 3 0.0005
535 STRESS CARDIOMYOPATHY 3 0.0005
536 IMPAIRED GASTRIC EMPTYING 7 0.0005
537 THROAT IRRITATION 23 0.0005
538 ELECTROCARDIOGRAM ABNORMAL 4 0.0005
539 HEAD DISCOMFORT 9 0.0005
540 TRICUSPID VALVE INCOMPETENCE 4 0.0005
541 WRIST FRACTURE 6 0.0005
542 CARPAL TUNNEL SYNDROME 7 0.0005
543 LEUKOCYTOSIS 9 0.0005
544 FRUSTRATION TOLERANCE DECREASED 4 0.0005
545 GASTRITIS 13 0.0005
546 HYPOTHERMIA 5 0.0005
547 LOSS OF CONSCIOUSNESS 63 0.0005
548 HICCUPS 4 0.0005
549 SPINAL OPERATION 6 0.0005
550 UPPER-AIRWAY COUGH SYNDROME 4 0.0005
551 SPINAL COMPRESSION FRACTURE 4 0.0005
552 COUGH 135 0.0005
553 EXPIRED PRODUCT ADMINISTERED 16 0.0005
554 WEIGHT DECREASED 132 0.0005
555 LETHARGY 27 0.0005
556 WHITE BLOOD CELL COUNT INCREASED 18 0.0005
557 ASTHENIA 176 0.0005
558 BLOOD PRESSURE DECREASED 31 0.0005
559 FEELING ABNORMAL 111 0.0005
560 ALTERED STATE OF CONSCIOUSNESS 10 0.0005
561 BACK INJURY 5 0.0005
562 DEHYDRATION 61 0.0005
563 HIP ARTHROPLASTY 7 0.0005
564 WOUND INFECTION 5 0.0005
565 WRONG DRUG ADMINISTERED 4 0.0004
566 THERAPEUTIC RESPONSE UNEXPECTED 20 0.0004
567 SKIN INFECTION 5 0.0004
568 ANGER 15 0.0004
569 OROPHARYNGEAL DISCOMFORT 4 0.0004
570 PNEUMOTHORAX 7 0.0004
571 TACHYPNOEA 6 0.0004
572 GASTRIC HAEMORRHAGE 5 0.0004
573 PRODUCT DISTRIBUTION ISSUE 4 0.0004
574 ARTHRITIS INFECTIVE 2 0.0004
575 AMNESIA 28 0.0004
576 COORDINATION ABNORMAL 6 0.0004
577 RIGHT VENTRICULAR FAILURE 3 0.0004
578 FRACTURE 8 0.0004
579 BLOOD IRON DECREASED 5 0.0004
580 JOINT INJURY 9 0.0004
581 INCREASED APPETITE 8 0.0004
582 DEPRESSION 95 0.0004
583 DECREASED APPETITE 96 0.0004
584 DEATH 353 0.0004
585 MOUTH HAEMORRHAGE 3 0.0004
586 MUSCLE SPASMS 75 0.0004
587 POLLAKIURIA 17 0.0004
588 BLADDER DISORDER 4 0.0004
589 PRODUCT DOSE OMISSION ISSUE 118 0.0004
590 NEUROTOXICITY 7 0.0004
591 DIZZINESS 199 0.0004
592 COLD SWEAT 7 0.0004
593 MUSCULOSKELETAL CHEST PAIN 6 0.0004
594 FEMUR FRACTURE 12 0.0004
595 HAEMATOMA 10 0.0004
596 APNOEA 3 0.0004
597 RHABDOMYOLYSIS 16 0.0004
598 TORSADE DE POINTES 3 0.0004
599 PRODUCT USE COMPLAINT 6 0.0004
600 COMA 18 0.0004
601 RENAL PAIN 4 0.0004
602 ATRIAL FLUTTER 3 0.0004
603 RETCHING 8 0.0004
604 HYPOTENSION 75 0.0004
605 SENSORY LOSS 3 0.0004
606 BLOOD SODIUM DECREASED 7 0.0004
607 DECREASED ACTIVITY 4 0.0004
608 NEPHROLITHIASIS 17 0.0004
609 SYNCOPE 37 0.0004
610 LOWER LIMB FRACTURE 7 0.0004
611 ASTHENOPIA 2 0.0004
612 CONTUSION 35 0.0004
613 DENTAL CARIES 4 0.0004
614 AGEUSIA 9 0.0004
615 STEVENS-JOHNSON SYNDROME 8 0.0004
616 SENSATION OF FOREIGN BODY 3 0.0004
617 THERAPY NON-RESPONDER 16 0.0004
618 CARDIOVASCULAR DISORDER 9 0.0004
619 ACTIVITIES OF DAILY LIVING IMPAIRED 7 0.0004
620 IMPAIRED DRIVING ABILITY 4 0.0004
621 CARDIAC ARREST 29 0.0004
622 PERIPHERAL SWELLING 54 0.0004
623 PNEUMONIA 112 0.0003
624 ANOSMIA 5 0.0003
625 SEDATION 9 0.0003
626 RESPIRATORY FAILURE 25 0.0003
627 GRIP STRENGTH DECREASED 3 0.0003
628 RESPIRATORY RATE INCREASED 3 0.0003
629 ACCIDENT 4 0.0003
630 HAEMOLYTIC ANAEMIA 3 0.0003
631 HYPERLIPIDAEMIA 4 0.0003
632 GASTROINTESTINAL INFECTION 3 0.0003
633 OEDEMA 18 0.0003
634 OSTEOMYELITIS 6 0.0003
635 THERAPY CESSATION 17 0.0003
636 ECONOMIC PROBLEM 5 0.0003
637 ILL-DEFINED DISORDER 20 0.0003
638 DEVICE DELIVERY SYSTEM ISSUE 9 0.0003
639 CARDIAC FAILURE 26 0.0003
640 BLOOD ALKALINE PHOSPHATASE INCREASED 8 0.0003
641 NECK PAIN 18 0.0003
642 NEPHROPATHY 3 0.0003
643 SECRETION DISCHARGE 4 0.0003
644 LACERATION 3 0.0003
645 SQUAMOUS CELL CARCINOMA 3 0.0003
646 ARRHYTHMIA 15 0.0003
647 INTENTIONAL DOSE OMISSION 9 0.0003
648 HOSPITALISATION 48 0.0003
649 HYPOXIA 11 0.0003
650 SINUS BRADYCARDIA 3 0.0003
651 HERNIA 6 0.0003
652 WITHDRAWAL SYNDROME 13 0.0003
653 BACK DISORDER 5 0.0003
654 RESPIRATORY TRACT INFECTION 8 0.0003
655 KIDNEY INFECTION 6 0.0003
656 KNEE OPERATION 3 0.0003
657 OEDEMA PERIPHERAL 37 0.0003
658 LIGAMENT SPRAIN 3 0.0003
659 INABILITY TO AFFORD MEDICATION 3 0.0003
660 BRADYCARDIA 16 0.0003
661 DRUG INTOLERANCE 29 0.0003
662 DYSURIA 11 0.0003
663 BLOOD UREA INCREASED 5 0.0003
664 MALIGNANT MELANOMA 4 0.0003
665 CELLULITIS 15 0.0003
666 ABDOMINAL DISTENSION 31 0.0003
667 LIMB INJURY 8 0.0003
668 BODY TEMPERATURE INCREASED 6 0.0003
669 LOCALISED INFECTION 7 0.0003
670 NEURALGIA 7 0.0003
671 MALAISE 126 0.0003
672 SEPSIS 32 0.0003
673 SCRATCH 3 0.0003
674 PRODUCT DOSE OMISSION IN ERROR 8 0.0003
675 VISUAL IMPAIRMENT 35 0.0003
676 TACHYCARDIA 25 0.0003
677 BREAST PAIN 3 0.0003
678 FAECES DISCOLOURED 6 0.0003
679 PULMONARY THROMBOSIS 3 0.0003
680 STAPHYLOCOCCAL INFECTION 9 0.0003
681 PRODUCTIVE COUGH 13 0.0003
682 INFLAMMATION 14 0.0003
683 DRUG INEFFECTIVE 356 0.0003
684 ARTHROPOD BITE 2 0.0003
685 OBSTRUCTIVE AIRWAYS DISORDER 3 0.0003
686 BACTERIAL INFECTION 5 0.0003
687 NERVOUSNESS 14 0.0003
688 NEPHROPATHY TOXIC 3 0.0003
689 ATRIAL FIBRILLATION 26 0.0003
690 FATIGUE 207 0.0003
691 EYE INFECTION 3 0.0003
692 INTESTINAL OBSTRUCTION 10 0.0003
693 DRUG ABUSE 22 0.0003
694 COLITIS 10 0.0003
695 SCAB 3 0.0003
696 FEELING JITTERY 5 0.0003
697 DISCOMFORT 16 0.0003
698 SUICIDAL IDEATION 24 0.0003
699 SLEEP APNOEA SYNDROME 5 0.0003
700 EPILEPSY 8 0.0003
701 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 47 0.0003
702 POST PROCEDURAL COMPLICATION 5 0.0003
703 HYPOKALAEMIA 12 0.0003
704 PALLOR 7 0.0003
705 THERAPY PARTIAL RESPONDER 4 0.0003
706 HYPOACUSIS 11 0.0003
707 ARTERIAL OCCLUSIVE DISEASE 2 0.0003
708 INCORRECT DOSE ADMINISTERED 58 0.0003
709 HYPOAESTHESIA 38 0.0003
710 DIVERTICULITIS 7 0.0003
711 ILLNESS 26 0.0003
712 NEUROPATHY PERIPHERAL 24 0.0003
713 HOT FLUSH 19 0.0003
714 MACULAR DEGENERATION 3 0.0003
715 SEIZURE 29 0.0003
716 HYPOTHYROIDISM 8 0.0003
717 WOUND 7 0.0003
718 NAUSEA 198 0.0002
719 ADVERSE EVENT 23 0.0002
720 TARDIVE DYSKINESIA 7 0.0002
721 PRESYNCOPE 6 0.0002
722 GASTROINTESTINAL DISORDER 22 0.0002
723 CEREBRAL INFARCTION 6 0.0002
724 ASPHYXIA 2 0.0002
725 SMALL INTESTINAL OBSTRUCTION 3 0.0002
726 TENDON RUPTURE 3 0.0002
727 TOOTH EXTRACTION 3 0.0002
728 INJECTION SITE DISCOLOURATION 3 0.0002
729 DRUG WITHDRAWAL SYNDROME 21 0.0002
730 THERAPY INTERRUPTED 17 0.0002
731 KNEE ARTHROPLASTY 5 0.0002
732 MUSCLE ATROPHY 3 0.0002
733 INJECTION SITE IRRITATION 3 0.0002
734 ANOREXIA 3 0.0002
735 MUSCULOSKELETAL DISCOMFORT 4 0.0002
736 SKIN CANCER 5 0.0002
737 DISEASE RECURRENCE 11 0.0002
738 SUICIDE ATTEMPT 14 0.0002
739 PRODUCT DISPENSING ERROR 5 0.0002
740 BLOOD PRESSURE INCREASED 35 0.0002
741 INTERVERTEBRAL DISC PROTRUSION 5 0.0002
742 DRUG ADMINISTRATION ERROR 7 0.0002
743 ABDOMINAL PAIN 53 0.0002
744 TOOTH INFECTION 3 0.0002
745 NERVOUS SYSTEM DISORDER 7 0.0002
746 THIRST 4 0.0002
747 GOUT 4 0.0002
748 EXTRA DOSE ADMINISTERED 9 0.0002
749 SINUS CONGESTION 3 0.0002
750 HYPERTENSION 47 0.0002
751 SURGERY 13 0.0002
752 GASTROENTERITIS VIRAL 4 0.0002
753 DRUG EFFECT INCOMPLETE 8 0.0002
754 MOOD SWINGS 7 0.0002
755 RESPIRATORY ARREST 6 0.0002
756 PROCEDURAL PAIN 6 0.0002
757 ROAD TRAFFIC ACCIDENT 9 0.0002
758 APHONIA 3 0.0002
759 BLOOD CREATININE INCREASED 14 0.0002
760 THERAPEUTIC RESPONSE DECREASED 13 0.0002
761 RENAL IMPAIRMENT 18 0.0002
762 BLOOD TEST ABNORMAL 3 0.0002
763 PULMONARY FIBROSIS 4 0.0002
764 ATELECTASIS 2 0.0002
765 CEREBROVASCULAR ACCIDENT 35 0.0002
766 GASTROENTERITIS 3 0.0002
767 ABDOMINAL PAIN UPPER 42 0.0002
768 DISABILITY 4 0.0002
769 PRODUCT USE ISSUE 38 0.0002
770 HAEMATOCRIT DECREASED 4 0.0002
771 CATARACT 12 0.0002
772 DEVICE USE ERROR 7 0.0002
773 HAEMATOCHEZIA 11 0.0002
774 LACRIMATION INCREASED 6 0.0002
775 CORONARY ARTERY DISEASE 6 0.0002
776 HAEMATEMESIS 5 0.0002
777 TASTE DISORDER 4 0.0002
778 FEELING HOT 12 0.0002
779 CEREBRAL HAEMORRHAGE 7 0.0002
780 THYROID DISORDER 3 0.0002
781 DISEASE PROGRESSION 23 0.0002
782 ANKLE FRACTURE 3 0.0002
783 INFECTION 28 0.0002
784 SKIN ULCER 5 0.0002
785 CRYING 7 0.0002
786 C-REACTIVE PROTEIN INCREASED 7 0.0002
787 SWOLLEN TONGUE 6 0.0002
788 BRAIN FOG 3 0.0002
789 CYANOSIS 3 0.0002
790 EMOTIONAL DISTRESS 23 0.0002
791 RESPIRATORY TRACT CONGESTION 3 0.0002
792 OSTEOARTHRITIS 8 0.0002
793 RENAL FAILURE ACUTE 8 0.0002
794 OBESITY 3 0.0002
795 SCIATICA 3 0.0002
796 EAR INFECTION 5 0.0002
797 METABOLIC ACIDOSIS 6 0.0002
798 VOMITING 88 0.0002
799 IRRITABLE BOWEL SYNDROME 4 0.0002
800 MYOCARDIAL INFARCTION 32 0.0002
801 PAIN IN EXTREMITY 54 0.0002
802 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
803 DYSPEPSIA 18 0.0002
804 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 37 0.0002
805 HAEMORRHAGE 19 0.0002
806 HEART RATE INCREASED 18 0.0002
807 RESPIRATORY DISTRESS 5 0.0002
808 PAIN 111 0.0002
809 GAMMA-GLUTAMYLTRANSFERASE INCREASED 4 0.0002
810 OXYGEN SATURATION DECREASED 10 0.0002
811 CIRCULATORY COLLAPSE 3 0.0002
812 DRUG DOSE OMISSION 29 0.0002
813 SKIN DISCOLOURATION 8 0.0002
814 DEVICE DEFECTIVE 3 0.0002
815 DYSPNOEA 97 0.0002
816 INTENTIONAL PRODUCT MISUSE 15 0.0002
817 COVID-19 30 0.0002
818 RHINORRHOEA 11 0.0002
819 ACUTE RESPIRATORY DISTRESS SYNDROME 3 0.0002
820 DIABETES MELLITUS INADEQUATE CONTROL 3 0.0002
821 ISCHAEMIC STROKE 3 0.0002
822 GALLBLADDER DISORDER 3 0.0002
823 BACK PAIN 39 0.0002
824 CARDIO-RESPIRATORY ARREST 7 0.0002
825 CHEST PAIN 31 0.0002
826 RESPIRATORY DISORDER 5 0.0002
827 RENAL FAILURE 22 0.0002
828 VERTIGO 10 0.0002
829 ACCIDENTAL OVERDOSE 6 0.0002
830 MEDICATION ERROR 9 0.0002
831 ABASIA 4 0.0002
832 CARDIAC FAILURE CONGESTIVE 13 0.0002
833 DYSGEUSIA 12 0.0002
834 ABDOMINAL DISCOMFORT 27 0.0002
835 CARDIAC DISORDER 15 0.0002
836 BLOOD URINE PRESENT 3 0.0002
837 ERECTILE DYSFUNCTION 4 0.0002
838 OVERDOSE 33 0.0002
839 TINNITUS 7 0.0002
840 IMPAIRED HEALING 5 0.0002
841 WEIGHT INCREASED 34 0.0002
842 SINUS DISORDER 3 0.0002
843 ADVERSE REACTION 2 0.0002
844 ACUTE KIDNEY INJURY 23 0.0002
845 VIRAL INFECTION 5 0.0002
846 LIP SWELLING 5 0.0001
847 SPINAL FRACTURE 3 0.0001
848 INTENTIONAL SELF-INJURY 3 0.0001
849 PLEURAL EFFUSION 9 0.0001
850 PULMONARY EMBOLISM 14 0.0001
851 MYALGIA 25 0.0001
852 AKATHISIA 2 0.0001
853 PARAESTHESIA 23 0.0001
854 INJECTION SITE WARMTH 3 0.0001
855 PERITONITIS 3 0.0001
856 PULMONARY HYPERTENSION 3 0.0001
857 THROMBOCYTOPENIA 16 0.0001
858 RASH MACULAR 5 0.0001
859 BURNING SENSATION 10 0.0001
860 HEART RATE DECREASED 5 0.0001
861 DIARRHOEA 91 0.0001
862 JOINT SWELLING 17 0.0001
863 HERPES ZOSTER 8 0.0001
864 ACCIDENTAL UNDERDOSE 2 0.0001
865 VISION BLURRED 19 0.0001
866 FLUID RETENTION 7 0.0001
867 PALPITATIONS 16 0.0001
868 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
869 INJECTION SITE MASS 5 0.0001
870 RENAL INJURY 4 0.0001
871 INFLUENZA 15 0.0001
872 SNEEZING 3 0.0001
873 MUSCULOSKELETAL PAIN 7 0.0001
874 BLOOD POTASSIUM DECREASED 4 0.0001
875 PYREXIA 46 0.0001
876 PRODUCT AVAILABILITY ISSUE 3 0.0001
877 ALANINE AMINOTRANSFERASE INCREASED 8 0.0001
878 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 3 0.0001
879 DEVICE MALFUNCTION 9 0.0001
880 CHEST DISCOMFORT 13 0.0001
881 ERYTHEMA 26 0.0001
882 ARTHROPATHY 7 0.0001
883 INTENTIONAL PRODUCT USE ISSUE 11 0.0001
884 RASH ERYTHEMATOUS 6 0.0001
885 PRODUCT USE IN UNAPPROVED INDICATION 31 0.0001
886 HEPATIC CANCER 3 0.0001
887 INTENTIONAL OVERDOSE 8 0.0001
888 TOXICITY TO VARIOUS AGENTS 21 0.0001
889 THROMBOSIS 10 0.0001
890 HYPOGLYCAEMIA 6 0.0001
891 DEVICE EXPULSION 8 0.0001
892 BLINDNESS 5 0.0001
893 PRODUCT SUBSTITUTION ISSUE 7 0.0001
894 OSTEOPOROSIS 5 0.0001
895 INJECTION SITE ERYTHEMA 15 0.0001
896 ANAEMIA 23 0.0001
897 FUNGAL INFECTION 4 0.0001
898 CHILLS 14 0.0001
899 CHRONIC KIDNEY DISEASE 9 0.0001
900 HAEMATURIA 4 0.0001
901 OFF LABEL USE 102 0.0001
902 HEADACHE 72 0.0001
903 DEAFNESS 3 0.0001
904 ARTHRITIS 9 0.0001
905 ANHEDONIA 3 0.0001
906 ASPARTATE AMINOTRANSFERASE INCREASED 6 0.0001
907 PRODUCT ADHESION ISSUE 4 0.0001
908 JAUNDICE 3 0.0001
909 ELECTROCARDIOGRAM QT PROLONGED 4 0.0001
910 ARTHRALGIA 45 0.0001
911 FEELING COLD 3 0.0001
912 GASTROINTESTINAL HAEMORRHAGE 9 0.0001
913 SWELLING FACE 7 0.0001
914 RENAL DISORDER 5 0.0001
915 SWELLING 10 0.0001
916 BLISTER 6 0.0001
917 FLATULENCE 6 0.0001
918 RED BLOOD CELL COUNT DECREASED 3 0.0001
919 ANGINA PECTORIS 3 0.0001
920 INJECTION SITE PRURITUS 7 0.0001
921 BLOOD GLUCOSE DECREASED 5 0.0001
922 PANCREATIC CARCINOMA 3 0.0001
923 PLASMA CELL MYELOMA 4 0.0001
924 LUNG DISORDER 5 0.0001
925 INJURY 7 0.0001
926 NASOPHARYNGITIS 18 0.0001
927 HAEMOGLOBIN DECREASED 10 0.0001
928 OROPHARYNGEAL PAIN 9 0.0001
929 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 5 0.0001
930 EPISTAXIS 7 0.0001
931 RECTAL HAEMORRHAGE 4 0.0001
932 NIGHT SWEATS 3 0.0001
933 RASH PRURITIC 5 0.0001
934 CHOLELITHIASIS 3 0.0001
935 EYE DISORDER 3 0.0001
936 VISUAL ACUITY REDUCED 3 0.0001
937 SKIN DISORDER 3 0.0001
938 PULMONARY OEDEMA 4 0.0001
939 EYE PAIN 5 0.0001
940 GASTROOESOPHAGEAL REFLUX DISEASE 7 0.0001
941 TREATMENT FAILURE 7 0.0001
942 INCORRECT ROUTE OF DRUG ADMINISTRATION 3 0.0001
943 BRONCHITIS 6 0.0001
944 PRODUCT QUALITY ISSUE 11 0.0001
945 DRY EYE 4 0.0001
946 DYSPNOEA EXERTIONAL 3 0.0001
947 ABDOMINAL PAIN LOWER 2 0.0001
948 DIABETES MELLITUS 6 0.0001
949 RASH 34 0.0001
950 DEEP VEIN THROMBOSIS 5 0.0001
951 ECZEMA 4 0.0001
952 APPLICATION SITE ERYTHEMA 2 0.0001
953 PANCREATITIS 4 0.0001
954 NEOPLASM MALIGNANT 5 0.0001
955 DEPENDENCE 4 0.0001
956 HYPERSENSITIVITY 13 0.0001
957 SKIN BURNING SENSATION 5 0.0001
958 EYE IRRITATION 4 0.0001
959 SEPTIC SHOCK 3 0.0001
960 NASAL CONGESTION 4 0.0001
961 LIVER DISORDER 3 0.0001
962 NEUTROPENIA 9 0.0001
963 LOWER RESPIRATORY TRACT INFECTION 3 0.0001
964 INJECTION SITE SWELLING 5 0.0001
965 PROSTATE CANCER 5 0.0001
966 LEUKOPENIA 3 0.0001
967 PRURITUS 23 0.0001
968 SKIN EXFOLIATION 5 0.0001
969 SINUSITIS 6 0.0001
970 INJECTION SITE REACTION 4 0.0001
971 PLATELET COUNT DECREASED 6 0.0001
972 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 4 0.0001
973 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
974 BREAST CANCER 5 0.0001
975 ASTHMA 6 0.0001
976 BONE PAIN 3 0.0001
977 INJECTION SITE BRUISING 4 0.0001
978 INJECTION SITE HAEMORRHAGE 4 0.0001
979 STOMATITIS 3 0.0000
980 INFLUENZA LIKE ILLNESS 4 0.0000
981 ALOPECIA 9 0.0000
982 PRODUCT STORAGE ERROR 4 0.0000
983 DRY SKIN 6 0.0000
984 MIGRAINE 4 0.0000
985 FLUSHING 4 0.0000
986 DRUG DEPENDENCE 6 0.0000
987 MATERNAL EXPOSURE DURING PREGNANCY 3 0.0000
988 NO ADVERSE EVENT 6 0.0000
989 BLOOD GLUCOSE INCREASED 6 0.0000
990 URTICARIA 5 0.0000
991 INJECTION SITE PAIN 9 0.0000
992 ACNE 2 0.0000